Join the Contraception group to help and get support from people like you.
Contraception News (Page 4)
Related terms: Contraceptive, Contraception Pill, Contraceptive Pill
U.S. Births Continue to Fall, Dropping by 17% Since 2007
TUESDAY, Aug. 20, 2024 – Final government data finds the number of U.S. births falling by 2% last year compared to 2022, continuing a decades-long decline. Overall, annual U.S. birth numbers have...
Hormonal Meds for Birth Control, Menopause Linked to Brain Tumors
THURSDAY, March 28, 2024 – The contraceptive injection Depo-Provera and two drugs used for menopause relief could be linked to a heightened risk for brain tumors in some women, a new study warns....
FDA Approves Opill (norgestrel) OTC Daily Oral Contraceptive
DUBLIN, July 13, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, announced today that the U.S. Food and Drug Administration (FDA) approved ...
FDA Approves Nextstellis (drospirenone and estetrol) Oral Contraceptive for Birth Control
GREENVILLE, N.C., April 16, 2021 /PRNewswire/ – Mayne Pharma announced today that the U.S. Food and Drug Administration (FDA) has approved Nextstellis (3 mg drospirenone [DRSP] and 14.2 mg estetrol...
FDA Approves Phexxi (lactic acid, citric acid and potassium bitartrate) Non-Hormonal Prescription Gel for the Prevention of Pregnancy
SAN DIEGO, May 22, 2020 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced that the U.S. Food and Drug Administration (FDA) has approved Phexxi™ (lactic acid, citric acid and pota...
FDA Approves Twirla (levonorgestrel and ethinyl estradiol) Contraceptive Patch
PRINCETON, N.J., Feb. 14, 2020 (GLOBE NEWSWIRE) – Agile Therapeutics, Inc., (Nasdaq: AGRX) (Agile or the Company), a forward-thinking women’s healthcare company, today announced that the U.S. Food a...
FDA Approves Liletta (levonorgestrel-releasing intrauterine system) to Prevent Pregnancy for up to Six Years
SAN FRANCISCO and DUBLIN October 28, 2019 – Medicines360, a global nonprofit organization with a mission to expand women’s access to quality medicines, and Allergan plc (NYSE: AGN), a leading global p...
FDA Medwatch Alert: Janssen Issues Voluntary Nationwide Recall for One Lot of Ortho-Novum 1/35 and Two Lots of Ortho-Novum 7/7/7 Due to Incorrect Veridate Dispenser Instructions
The Ortho-Novum® product itself remains safe and effective for use with the appropriate dispenser instructionsTITUSVILLE, NJ – November 2, 2018 – Janssen Pharmaceuticals, Inc. has initiated a vo...
FDA Approves Liletta (levonorgestrel-releasing intrauterine system) to Prevent Pregnancy for up to Five Years
DUBLIN and SAN FRANCISCO October 16, 2018 – Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Medicines360, a global nonprofit women’s health pharmaceutical company with a mis...
FDA Approves Annovera (segesterone acetate and ethinyl estradiol) Vaginal Contraceptive System
NEW YORK, Aug. 10, 2018 /PRNewswire/ – The Population Council, a global nonprofit research organization, announced it has received U.S. Food and Drug Administration (FDA) approval for Annovera™ (...
FDA Medwatch Alert: Essure Permanent Birth Control System by Bayer Healthcare: Announcement - FDA Restricts the Sale and Distribution
ISSUE: The FDA is aware that some women have received the Essure device without being adequately informed of Essure’s risks. In order for this device to meet reasonable assurance of safety and e...
Avion Pharmaceuticals Announces FDA Approval of Balcoltra (levonorgestrel and ethinyl estradiol tablets and ferrous bisglycinate tablets) Oral Contraceptive
ATLANTA, Jan. 17, 2018 /PRNewswire/ – Avion Pharmaceuticals, LLC, the makers of the Prenate® line of prescription prenatal vitamins, received approval of its new drug application (NDA) for the oral ...
FDA Approves Liletta (levonorgestrel-releasing intrauterine system) to Prevent Pregnancy for up to Four Years
August 6, 2017 – Allergan plc (NYSE:AGN), a leading global pharmaceutical company, and Medicines360, a global nonprofit women's health pharmaceutical company with a mission of expanding access to...
FDA Medwatch Alert: Mibelas 24 Fe Chewable Tablets by Lupin Pharmaceuticals Inc.: Recall - Out of Sequence Tablets and Missing Expiry/Lot Information
ISSUE: Lupin Pharmaceuticals Inc. announced a recall of lot L600518, Exp 05/18 of Mibelas 24 Fe (Norethindrone Acetate and Ethinyl Estradiol 1 mg/0.02 mg chewable and ferrous fumarate 75 mg) Tablets ...
FDA Medwatch Alert: Essure Permanent Birth Control System by Bayer Healthcare: FDA Announcement - Label Changes
ISSUE: Essure labeling now includes the addition of a boxed warning and a Patient Decision Checklist, both intended to support patient counseling and understanding of benefits and risks associated...
Further information
Related condition support groups
Emergency Contraception, Postcoital Contraception
Related drug support groups
Depo-Provera, Nexplanon, Provera, NuvaRing, Mirena, Implanon, levonorgestrel, Sprintec, Loestrin 24 Fe, Yasmin, Lo Loestrin Fe, medroxyprogesterone, Kyleena